Hydroxytamoxifen interaction with human erythrocyte membrane and induction of permeabilization and subsequent hemolysis
4-Hydroxytamoxifen (OHTAM) is the most active metabolite of the widely prescribed anticancer drug tamoxifen (TAM) used in breast cancer therapy. This work describes the effects of OHTAM on isolated human erythrocytes, using standardized test conditions, to check for a putative contribution to the TA...
Main Author: | |
---|---|
Other Authors: | , , |
Format: | article |
Language: | eng |
Published: |
2001
|
Subjects: | |
Online Access: | http://hdl.handle.net/10316/5795 |
Country: | Portugal |
Oai: | oai:estudogeral.sib.uc.pt:10316/5795 |